Here are 10 drug and medical device recalls that the FDA reported in July:

The Biden administration is dispensing more than a million Jynneos monkeypox vaccines in the coming weeks, but the next shipment isn't planned until October at the earliest, leaving the U.S. in a waiting room for three months, according to The Washington Post. 

Fort Worth, Texas-based Rhino Health, the only manufacturer of nitrile gloves in the United States, received $58 million to expand its facilities in south Fort Worth. The company received the funding from New Markets Tax Credit with capital from five community development entity leaders. 

Minneapolis-based Medtronic has recalled Palindrome and Mahurkar hemodialysis catheters, which the FDA deemed a class 1 recall, the highest level.

Here are 10 health systems that have posted job listings for supply chain expertise in the last week: 

The FDA cleared the way for Bavarian Nordic, the world's only vaccine-maker with an authorized monkeypox vaccine, to manufacture more supply after authorizing its Denmark facility July 27. 

Nearly 800,000 additional monkeypox vaccine doses will soon be available for distribution to states and jurisdictions, healthcare leaders said during a July 28 HHS news conference. 

Pfizer's Paxlovid beat Merck's COVID-19 antiviral treatment in sales in May, but the boom in demand is slowing down as less than half of Pfizer's production capacity has been sold, according to data surveillance company Airfinity. 

The state with the most monkeypox cases, New York, only had 1,000 monkeypox vaccines while the U.S. had 372,000 doses waiting overseas, The New York Times reported July 25. 

The world's only company with an authorized monkeypox vaccine, Bavarian Nordic, may soon be running 24/7 after the World Health Organization defined the current outbreak as a global health emergency, according to Bloomberg. 

Material science company 3M said it plans to spin off its healthcare ventures into two publicly traded companies, New 3M and Health Care, by the end of 2023. 

There aren't enough monkeypox vaccines to go around.

The healthcare sector is reexamining how to build greater flexibility into supply chains while preserving efficiency and preparing for future shocks to the system.

Medline Industries expects to lay off 97 workers as it closes a facility in Rowan County, N.C., according to a July 22 report from The News & Observer. 

Healthcare investment firm Patient Square Capital plans to acquire Hanger, an Austin, Texas-based orthotic and prosthetic devicemaker, for $1.25 billion. 

Citing eight product malfunctions, Smiths Medical has recalled more than 118,000 syringe infusion pumps after reports of one death and seven serious injuries. 

Danville, Pa.-based Geisinger health system is partnering with Excelerate to reduce its supply chain costs up to 20 percent, according to a July 20 press release. 

In the most serious type of recall, American Contract Systems has recalled 99,900 distributed COVID-19 test kits after the FDA deemed the facility "uncontrolled" because of untrained workers.

The shortage of resin, an ingredient medical manufacturers use in plastic products, isn't affecting hospitals equally.